Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and to prevent NSAID‑induced gastric ulcers.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nolpaza (pantoprazole) is indicated for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and acid reflux symptoms. - Erosive esophagitis: promotes healing of acid‑damaged esophageal lining. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with any medication and should be monitored by a healthcare professional.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, usually transient. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation, reduced urine output. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before initiating therapy, consider patient‑specific factors and monitor for potential risks.

- Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Use with caution in elderly: higher incidence of adverse effects. - Store at room temperature: keep in the original container, protect from moisture.

Pantoprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular risk. - Atazanavir: decreased absorption, leading to sub‑therapeutic antiviral levels. - High‑dose methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR, requiring more frequent monitoring. - Digoxin: possible increase in serum concentration, watch for toxicity signs. - Diazepam: may raise plasma levels, observe for enhanced sedation.